FDA's Proposed Rule On LDT Regulation And The Debate Over Agency Deference

Earlier this month, the Food and Drug Administration ('FDA' or 'the Agency') issued a highly anticipated proposed rule outlining the regulatory framework and implementation plan for Laboratory Developed Tests ('LDTs').1 [...]